Patents by Inventor Liza Leventhal

Liza Leventhal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230242909
    Abstract: The present invention relates to compositions and methods for treating neurodegeneration and neurodegenerative diseases associated with axonal degeneration. Neurodegeneration and neurodegenerative diseases associated with axonal degeneration are treated with therapies comprising SARM1 inhibitors such as SARM1 antisense oligonucleotides.
    Type: Application
    Filed: November 25, 2020
    Publication date: August 3, 2023
    Inventors: Liza LEVENTHAL, Thomas ENGBER, Raul Eduardo KRAUSS, Rajesh DEVRAJ, Robert Owen HUGHES, Todd BOSANAC, Sudhir AGRAWAL, Marco A. PASSINI
  • Publication number: 20080227850
    Abstract: The present invention relates to the use of compounds and composition of compounds that modulate norepinephrine levels for the prevention and treatment of vasomotor symptoms, such as hot flush, caused by, inter alia, thermoregulatory dysfunctions.
    Type: Application
    Filed: January 21, 2008
    Publication date: September 18, 2008
    Applicant: Wyeth
    Inventors: Darlene Coleman Deecher, Istvan Jozsef Merchenthaler, Liza Leventhal, Kimberly Jean Sipe, Lawrence Thomas O'Connor
  • Patent number: 7345096
    Abstract: The present invention relates to the use of compounds and composition of compounds that modulate norepinephrine levels for the prevention and treatment of vasomotor symptoms, such as hot flush, caused by, inter alia, thermoregulatory dysfunctions.
    Type: Grant
    Filed: October 14, 2003
    Date of Patent: March 18, 2008
    Assignee: Wyeth
    Inventors: Darlene Coleman Deecher, Istvan Jozsef Merchenthaler, Liza Leventhal, Kimberly Jean Sipe, Lawrence Thomas O'Connor
  • Publication number: 20050165082
    Abstract: The present invention relates to methods of treating at least one vasomotor symptom such as hot flush, caused by, inter alia, thermoregulatory dysfunction, in a subject in need thereof by administering to the subject a compound or composition of compounds that modulate the V1b receptor.
    Type: Application
    Filed: December 15, 2004
    Publication date: July 28, 2005
    Applicant: Wyeth
    Inventors: Liza Leventhal, Robert Ring
  • Publication number: 20050130987
    Abstract: The present invention relates to selective adrenergica2B antagonists alone, selective adrenergic?2B antagonists in combination with norepinephrine reuptake inhibitors (NRI) (as a single compound or as a combination of two or more compounds), or selective adrenergic?2B antagonists in combination with dual norepinephrine reuptake inhibitors/serotonin reuptake inhibitors (NRI/SRI) (as a single compound or as a combination of two or more compounds) and methods of their use in the treatment of vasomotor symptoms.
    Type: Application
    Filed: October 12, 2004
    Publication date: June 16, 2005
    Applicant: Wyeth
    Inventors: Darlene Deecher, Chad Beyer, Liza Leventhal
  • Publication number: 20040152710
    Abstract: The present invention relates to the use of compounds and composition of compounds that modulate norepinephrine levels for the prevention and treatment of vasomotor symptoms, such as hot flush, caused by, inter alia, thermoregulatory dysfunctions.
    Type: Application
    Filed: October 14, 2003
    Publication date: August 5, 2004
    Inventors: Darlene Coleman Deecher, Istvan Jozsef Merchenthaler, Liza Leventhal, Kimberly Jean Sipe, Lawrence Thomas O'Connor
  • Publication number: 20040143008
    Abstract: The present invention relates to the use of compounds and composition of compounds that modulate norepinephrine levels for the prevention and treatment of vasomotor symptoms, such as hot flush, caused by, inter alia, thermoregulatory dysfunctions.
    Type: Application
    Filed: October 14, 2003
    Publication date: July 22, 2004
    Inventors: Darlene Coleman Deecher, Istvan Jozsef Merchenthaler, Liza Leventhal, Kimberly Jean Sipe, Lawrence Thomas O'Connor
  • Publication number: 20040063721
    Abstract: The present invention relates to a method for treating thermoregulatory disorders by administering compounds and compositions of compounds which by modulating 5HT levels activate the 5HT2a receptor. The invention also relates to therapy using 5HT1a antagonists and SRIs in combination and pharmaceutical compositions and products containing it. It is emphasized that this abstract is provided to comply with the rules requiring an abstract that will allow a searcher or other reader to quickly ascertain the subject matter of the technical disclosure. It is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims.
    Type: Application
    Filed: August 14, 2003
    Publication date: April 1, 2004
    Applicant: Wyeth
    Inventors: Darlene Coleman Deecher, Istvan Jozsef Merchenthaler, Liza Leventhal, Kimberly Jean Sipe, Lawrence Thomas O'Connor, Terrance Andree